Italy Home Infusion Therapy Market Size & Outlook, 2025-2030
Related Markets
Italy home infusion therapy market highlights
- The Italy home infusion therapy market generated a revenue of USD 1,017.6 million in 2024 and is expected to reach USD 1,728.9 million by 2030.
- The Italy market is expected to grow at a CAGR of 9.3% from 2025 to 2030.
- In terms of segment, anti-infective was the largest revenue generating application in 2024.
- Endocrinology is the most lucrative application segment registering the fastest growth during the forecast period.
Home infusion therapy market data book summary
| Market revenue in 2024 | USD 1,017.6 million |
| Market revenue in 2030 | USD 1,728.9 million |
| Growth rate | 9.3% (CAGR from 2025 to 2030) |
| Largest segment | Anti-infective |
| Fastest growing segment | Endocrinology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others Application |
| Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
Other key industry trends
- In terms of revenue, Italy accounted for 2.6% of the global home infusion therapy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany home infusion therapy market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 2,883.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Home Infusion Therapy Market Scope
Home Infusion Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Caesarea Medical Electronics | View profile | 101-250 | Caesarea, Hefa, Israel, Asia | http://cme-infusion.com |
| Fresenius Medical Care AG | View profile | 119845 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.freseniusmedicalcare.com |
| ICU Medical Inc | View profile | 14000 | 951 Calle Amanecer, San Clemente, CA, United States, 92673 | https://www.icumed.com |
| CVS Group PLC | View profile | 9100 | Owen Road, CVS House, Diss, Norfolk, United Kingdom, IP22 4ER | https://www.cvsukltd.co.uk |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | http://www.bbraunusa.com |
| BrightSpring Health Services Inc | View profile | 35000 | 805 N. Whittington Parkway, Louisville, KY, United States, 40222 | https://www.brightspringhealth.com |
| UnitedHealth Group Inc | View profile | 440000 | 9900 Bren Road East, UnitedHealth Group Center, Minnetonka, MN, United States, 55343 | https://www.unitedhealthgroup.com |
| Walgreens Boots Alliance Inc | View profile | 331000 | 108 Wilmot Road, Deerfield, IL, United States, 60015 | https://www.walgreensbootsalliance.com |
| Smiths Group PLC | View profile | 15000 | 11-12 St James’s Square, 4th Floor, London, United Kingdom, SW1Y 4LB | https://www.smiths.com |
| Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Italy home infusion therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 28.94% in 2024. Horizon Databook has segmented the Italy home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, others application covering the revenue growth of each sub-segment from 2018 to 2030.
Italy is one of the super-aged countries with high percentage of geriatric population. According to the World Bank Group data, the country’s population aged 65 & above accounted for 23.0% of the total population in 2019. Furthermore, according to Cable News Network, by 2030, around 26.8% of the country’s population is estimated to be aged above 65.
Presence of a large geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. In Italy, long-term care is provided mainly in residential, semi-residential, or community home care facilities. Community home care in Italy is publicly funded. This is expected to have a positive impact on home infusion therapy market.
Italy was the first and one of the worse hit European nations by COVID-19 pandemic. Factors such as shortage of hospital beds & other related medical infrastructure, high disease prevalence, and impact of the pandemic on country’s economy & medical system are anticipated to boost the need for investments in proper home-based care models for effective management of the disease.
Reasons to subscribe to Italy home infusion therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy home infusion therapy market databook
-
Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Italy home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy home infusion therapy market size, by application, 2018-2030 (US$M)
Italy Home Infusion Therapy Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
